David Shaw’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
CB
David Shaw's IBB Position: Q2 2026 in Review
David Shaw reduced its iShares Biotechnology ETF (IBB) stake by 82% in Q2 2026, selling an estimated $55M and leaving 68,971 shares worth $13.1M. The position accounts for 0.01% of the portfolio, ranked #1608.
David Shaw first reported a position in IBB in Q2 2015 and has held it in 15 quarters since. The position peaked at $65.7M in Q1 2026. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.
- David Shaw held 68,971 shares of iShares Biotechnology ETF worth $13.1M as of Q2 2026.
- David Shaw sold 320,085 iShares Biotechnology ETF shares in Q2 2026, an estimated $55M.
- iShares Biotechnology ETF made up 0.01% of David Shaw's portfolio in Q2 2026, its #1608 holding.
- David Shaw first reported a position in iShares Biotechnology ETF in Q2 2015 and has held it in 15 quarters since.
- David Shaw's iShares Biotechnology ETF position peaked at $65.7M in Q1 2026.
- 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.
Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.